Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: AT-101 enhances gefitinib sensitivity in non-small cell lung cancer with EGFR T790M mutations

Fig. 4

Effect of combination treatment with AT-101 and gefitinib on apoptosis of NSCLC cells with the T790M mutation. Cells were incubated with 5 μM AT-101 and/or 1 μM gefitinib for 24h, and apoptosis was assessed by Annexin V/PI staining and fluorescence activated cell-sorting (FACS) analysis. Columns representing the flow cytometry data are presented on the top. Bars represent the mean ± SD of three independent experiments. ***, P < 0.001

Back to article page